Search

Author/Creator Brice, P.

11. Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas. (1st December 2019)

Authors:
Dumont, M.; Ram‐Wolff, C.; Roelens, M.; Brice, P.; Peffault de Latour, R.; Battistella, M.; Madelaine, I.; Delyon, J.; Herms, F.; Bouaziz, J.‐D.; Moins‐Teisserenc, H.; Lebbé, C.; Bagot, M.; de Masson, A.
Journal:
British journal of dermatology
Issue:
Volume 181:Number 6(2019)
Page Start:
1315
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas. (22nd August 2019)

Authors:
Dumont, M.; Ram‐Wolff, C.; Roelens, M.; Brice, P.; Peffault de Latour, R.; Battistella, M.; Madelaine, I.; Delyon, J.; Herms, F.; Bouaziz, J.‐D.; Moins‐Teisserenc, H.; Lebbé, C.; Bagot, M.; de Masson, A.
Journal:
British journal of dermatology
Issue:
Volume 181:Number 6(2019)
Page Start:
1315
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. GENE‐EXPRESSION PROFILING PREDICTS DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA. (June 2017)

Authors:
Huet, S.; Tesson, B.; Jais, J.; Feldman, A.L.; Magnano, L.; Thomas, E.; Traverse‐Glehen, A.; Albaud, B.; Xerri, L.; Ansell, S.; Tarte, K.; Boyault, S.; Haioun, C.; Link, B.; Feugier, P.; Lopez‐Guillermo, A.; Brice, P.; Hayette, S.; Jardin, F.; Offner, F.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Ifosfamide and etoposide in advanced‐stage, relapsed or refractory primary cutaneous T‐cell lymphomas. (13th July 2020)

Authors:
Dangien, A.; Ram‐Wolff, C.; Brice, P.; Battistella, M.; Roelens, M.; Moins‐Teisserenc, H.; Peffault de Latour, R.; Mourah, S.; Bouaziz, J.‐D.; Lebbé, C.; Bagot, M.; de Masson, A.
Journal:
British journal of dermatology
Issue:
Volume 183:Number 5(2020)
Page Start:
961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Ifosfamide and etoposide in advanced‐stage, relapsed or refractory primary cutaneous T‐cell lymphomas. (1st November 2020)

Authors:
Dangien, A.; Ram‐Wolff, C.; Brice, P.; Battistella, M.; Roelens, M.; Moins‐Teisserenc, H.; Peffault de Latour, R.; Mourah, S.; Bouaziz, J.‐D.; Lebbé, C.; Bagot, M.; de Masson, A.
Journal:
British journal of dermatology
Issue:
Volume 183:Number 5(2020)
Page Start:
961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome. (1st August 2021)

Authors:
Calvani, J.; de Masson, A.; de Margerie‐Mellon, C.; de Kerviler, É.; Ram‐Wolff, C.; Gruber, A.; Meignin, V.; Brice, P.; Sadoux, A.; Mourah, S.; Bagot, M.; Battistella, M.
Journal:
British journal of dermatology
Issue:
Volume 185:Number 2(2021)
Page Start:
419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome. (1st March 2021)

Authors:
Calvani, J.; de Masson, A.; de Margerie‐Mellon, C.; de Kerviler, É.; Ram‐Wolff, C.; Gruber, A.; Meignin, V.; Brice, P.; Sadoux, A.; Mourah, S.; Bagot, M.; Battistella, M.
Journal:
British journal of dermatology
Issue:
Volume 185:Number 2(2021)
Page Start:
419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Long-term clinical outcome and HAVCR2 mutations in 70 patients with subcutaneous panniculitis-like T-cell lymphoma: a study from the French Cutaneous Lymphoma Group. (2019)

Authors:
Sonigo, G.; Battistella, M.; Beylot-Barry, M.; Oro, S.; Franck, N.; Barete, S.; Boulinguez, S.; Dereure, O.; Bonnet, N.; Socie, G.; Brice, P.; Boccara, O.; Bodemer, C.; Adamski, H.; D'Incan, M.; Ortonne, N.; Fraitag, S.; Brunet-Possenti, F.; Dalle, S.; Suarez, F.
Journal:
European journal of cancer
Issue:
Volume 119(2019)Supplement 1
Page Start:
S7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Long‐term efficacy and safety of alemtuzumab in advanced primary cutaneous T‐cell lymphomas. (1st March 2014)

Authors:
de Masson, A.; Guitera, P.; Brice, P.; Moulonguet, I.; Mouly, F.; Bouaziz, J.‐D.; Battistella, M.; Madelaine, I.; Roux, J.; Ram‐Wolff, C.; Cayuela, J.‐M.; Bachelez, H.; Bensussan, A.; Michel, L.; Bagot, M.
Journal:
British journal of dermatology
Issue:
Volume 170:Number 3(2014:Mar.)
Page Start:
720
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗